Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of the Dialogues Time to Talk program in
subjects treated with Venlafaxine Extended Release (ER). Dialogues Time to Talk Program is a
patient management program, which aims to help patients achieve successful outcomes by
reinforcing physician treatment efforts, providing feedback to treating physicians, and
encouraging better physician-patient communications.